Higher specific activities of alkaline phosphatase and β-galactosidase for the cellular membrane integrity in young and old aged lithium treated rats

References

1. Wallenfels, K., and Weil, R, “ The Enzymes” P.D. Boyer, Academic Press, NY, 3rd Ed (1972) Vol. 7, 617.
2. Suzuki, Y., Sakuraba, H. and Oshima, A, “β- galactosidase deficiency (β-galactosidosis): GM1 gangliosidosis and Morquio B disease” The Metabolic and Molecular Bases of Inherited Disease, 7th Ed. (ed. C. R. Scriver, A. L. Beaudet and W. S. Sly) New York: McGrawHill (1995) pp. 2801-2810.
3. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW, “Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a” Cell (1997) 88, 593–602.
4. Lee BY1, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, Kleijer WJ, DiMaio D, Hwang ES, “Senescence-associated beta-galactosidase is lysosomal beta-galactosidase” Aging Cell (2006) 2, 187-95.
5. Bodnar AG1, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE, “Extension of life-span by introduction of telomerase into normal human cells” Science (1998) 279 (5349), 349-52.
6. Bernd van der Loo, Mark J. Fenton, Jorge D. Erusalimsky, “Cytochemical Detection of a Senescence- Associated β-Galactosidase in Endothelial and Smooth Muscle Cells from Human and Rabbit Blood Vessels” Experimental Cell Research (1998) Volume 241 (Issue 2), 309-315.
7. Sigal SH, Rajvanshi P, Gorla GR, Sokhi RP, Saxena R, Gebhard DR Jr, Reid LM, Gupta S, “Partial hepatectomy- induced polyploidy attenuates hepatocyte replication and activates cell aging events” Am. J. Physiol. (1999) 276, G1260–G1272. Prabha M et al. Higher specific activities of alkaline phosphatase and β-galactosidase for the cellular…. Indian Journal of Neurosciences, October-December,2016;2(4):97-104 104
8. Mishima K, Handa JT, Aotaki-Keen A et al., “Senescenceassociated β-galactosidase histochemistry for the primate eye” Invest. Ophthalmol Vis Sci (1999) 40, 1590- 1593.
9. Mae Wan Ho, John S. O'Brien, “Differential effect of chloride ions on β-galactosidase isoenzymes: A method for separate assay” Clinica Chimica Acta. (1971) Volume 32, Issue 3, 443-450.
10. Baker HJ, Lindsey JR. “Animal model: feline GM1 gangliosidosis” Am J Pathol. (1974) 74(3):649–652.
11. J. Alexander Lowden, John W. Callahan, Margaret G. Norman, John Stobo Prichard, “Juvenile GM1 Gangliosidosis Occurrence With Absence of Two β- Galactosidase Components” Arch Neurol. (1974) 31(3), 200-203.
12. Y Suzuki, K Suzuki, “Glycosphingolipid β-galactosidases II. Electrofocusing characterization in GM1- gangliosidosis” Journal of Biological Chemistry (1974) Vol. 249, No. 7, Issue of April 10, 2113-2117.
13. Suzuki Y, Oshima A, Nanba E in The Metabolic and Molecular Basis of Inherited Disease, eds Scriver C, Beaudet A, Sly W, Valle D. (McGraw Hill Inc. New York) (1995) 3:3775-3809.
14. McComb, R. B., Bowers Jr, G. N. and Posen, S., “Alkaline Phosphatase” New York, NY: Plenum Press (1979).
15. Millán JL., “Alkaline Phosphatases: Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes”. Purinergic Signal (2006) 2, 335-41.
16. Langer D, Hammer K, Koszalka P, Schrader J, Robson S, Zimmermann H, “Distribution of ectonucleotidases in the rodent brain revisited” Cell Tissue Res (2008) 334, 199–
17. Dorai DT, Bachhawat BK., “Purification and properties of brain alkaline phosphatase” J Neurochem. (1977) 3, 503–512.
18. Sood PP, Mulchandani MM. “A comparative study of histoenzymological mapping on the distribution of acid and alkaline phosphatases and succinic dehydrogenase in the spinal cord and medulla oblongata of mouse” Acta Histochem. (1977) 60 (2), 180–203.
19. Vorbrodt AW, “Ultrastructural cytochemistry of enzymatic activities in brain microvasculature” in Vorbrodt AW (ed.) Ultrastructural Cytochemistry of Blood-Brain Barrier Endothelium, G. Fischer, Stuttgart, (1988) 12–18.
20. Lander J W., Chason, J. L., Gonzalez, J, E., and Palutke, W, “Morphology and enzyme activity of rat cerebral capillaries” Lab investigation (1962) 11, 1253-1259.
21. Risau W, Hallmann R, Albrecht U, Henke-Fahle S, “Brain induces the expression of an early cell surface marker for blood brain barrier-specific endothelium” EMBO J (1986) 5, 3179 –3183.
22. Saiki, R., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. “Primerdirected enzymatic amplification of DNA with a thermostable DNA polymerase” Science (1988) 239, 487-
23. Braudbury,M.W.B, “The blood -brain barrier” Experimental Physiology (1993) 78,453-472.
24. Dermietzel R, Krause D, “Molecular anatomy of the blood-brain barrier as defined by immunocytochemistry” Int Rev Cytol. (1991) 127, 57–109.
25. Ferenc Joó, “The blood-brain barrier in vitro: The second decade” Neurochemistry International (1993) Volume 23, Issue 6, 499–52.
26. Rolf Dermietzel, Dorothee Krause, “Molecular Anatomy of the Blood-Brain Barrier as Defined by Immunocytochemistry” International Review of Cytology (1991) 127,57–109.
27. Hollister L.E., Csernansky J.G.. Clinical Pharmacology and Psychotherapeutic Drugs, Churchill-Livingstone Inc. New York (1990) 132-133.
28. Austin MPV, Souza FGM, Goodwin GM, “ Lithium augmentation in antidepressant-resistant patients. A quantitative analysis” Br J Psychiatry (1991) 159,510–
29. Bo Song, Qiang Ao, M.D., Zhen Wang, Weiqiang Liu, Ying Niu, Qin Shen, Huancong Zuo, Xiufang Zhang, and Yandao Gong, Master, “ Phosphorylation of tau protein over time in rats subjected to transient brain ischemia” Neural Regen Res. (2013) 8(34);3173–3182.
30. Hong M, Chen DC, Klein PS, Lee VM, “Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3” J Biol Chem. (1997) 272(40),25326-32.
31. Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, Dickson D, Duff K, “Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo”. Proc Natl Acad Sci U S A. (2005) 102(19), 6990-5.
32. Caccamo A.; Magri A.; Medina D. X.; Wisely E. V.; Lopez-Aranda M. F.; Silva A. J.; Oddo S, “mTOR regulates tau phosphorylation and degradation: implications for Alzheimer’s disease and other tauopathies” Aging Cell (2013) 12,370–380.
33. Lowry O H, Rosebrough NJ Farr AL, Randall RJ, “ Protein measurement with the Folin phenol reagent” J Biol Chem. (1951) 193(1),265-75.
34. M. M. Patil, Mallesha, K. V. Ramana and A. S. Bawa, “Characterization of partially purified ß-galactosidase from Bacillus Sp MTCC-864” Rec. Res.Sci.Tech. (2011) 3(9),84-87.
35. Gomori G, “The distribution of phosphatase in normal organs and tissues” J Cell Comp Physiol. (1941)17,71–
36. Prabha, M and Ravi, V. and Ramachandra Swamy, N, “Activity of hydrolytic enzymes in various regions of normal human brain tissue” Indian Journal of Clinical Biochemistry (2013);28(3),283-291.
37. Laemmli UK, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4” Nature (1970) 227(259),680–685.
38. Prabha M, N Ramachandra Swamy, V Ravi, “Specific activity of glycosidases in brain tumors and their expression in primary explants culture” J Biochem Tech (2013) 5(1),654-665.
39. Prabha M, “A Comparative biochemical study on hydrolytic enzymes in normal postmortem human brain, brain tumors and in their derived cell lines” Thesis (2005) Bangalore University/NIMHANS.
40. Guang Chen, Grazyna Rajkowska, Fu Du, Navid Seraji- Bozorgzad, and Husseini K. Manji.
41. “Enhancement of Hippocampal Neurogenesis by Lithium” Journal of Neurochemistry (2000) Vol. 75, No. 4, 1729–1734.
42. Folkert Verkaar, Mario van der Stelt , W. Matthijs Blankesteijn , Antoon A. van der Doelen, Guido J. R. Zaman, “Discovery of Novel Small Molecule Activators of b-Catenin Signaling” Febs Letters (2010) 584, 3850-